VISION – Strategies to strengthen scientific excellence and innovation in early diagnosis of stomach and colon cancer

Cancer is the second most common cause of death worldwide. Cancers of the digestive system are particularly common. Slovakia ranks third in Europe for the incidence of colorectal cancer and sixth for the incidence of pancreatic cancer.

Early detection is the key to better treatment success for patients and to improving their quality of life. In Slovakia, existing gaps in biomedical research on early detection and treatment of cancer represents need to be overcome.

The main objective of the EU-funded joint project “VISION” is to strengthen the scientific excellence and innovative capacity of the Slovak “Biomedicinske centrum Slovenskej akademie vied” (Biomedical Research Center of the Slovak Academy of Sciences) (BMC SAV) in the early detection of cancer.

This is realized by establishing a strategic partnership between the project coordinator BMC SAV and four interna-tionally recognized institutions, the Fraunhofer Institute for Biomedical Engineering IBMT (Germany), the Ramón y Cajal University Hospital Health Research Institute, represented by Servicio Madrileno de Salud (SERMAS) (Spain), the Medical School of National and Kapodistrian University of Athens (NKUA) (Greece) and the Norwegian Institute for Air Research (NILU) (Norway).

This collaboration contributes to overcome existing gaps in oncology research and reinforce the capacity for early diagnostics and innovative treatment approaches.

The transfer of knowledge and research ideas, the sharing of know-how, expertise and best practices, and the implementation of leading edge technologies will help to improve the quality of translational cancer research at BMC SAV, particularly in gastrointestinal cancers.

The cooperation and networking between the “VISION” partners helps to accelerate the personal and professional development of early-stage researchers and physicians. The involvement of the “VISION” partners in the supervision and co-supervision of PhD students will positively support the quality of education in the respective countries.

In addition, “VISION” supports regional activities, aiming to contribute to an increased public awareness of cancer and the importance of prevention.

Project funding: HORIZON 2020 GA Nr. 857381

Duration: 01.10.2019-30.09.2022

Project website:

Project coordinator:
Biomedical Research Center of the Slovak Academy of Sciences (BMC SAS), Bratislava, Slovakia

Project partners:
Fraunhofer-Institut für Biomedizinische Technik IBMT, Sulzbach, Germany
Servicio Madrileño de Salud (SERMAS), Madrid, Spain
Medical School of National and Kapodistrian University of Athens (NKUA), Athen, Greece
NILU – Norwegian Institute for Air Research, Kjeller, Norway

Contact at the Fraunhofer IBMT:
Dr. Yvonne Kohl
Working Group Nanotoxicology
Fraunhofer IBMT
Phone: +49 (0) 6897 9071 256

Media Contact

Dipl.-Phys. Annette Maurer-von der Gathen Fraunhofer-Institut für Biomedizinische Technik IBMT

Alle Nachrichten aus der Kategorie: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

Endangered botanic predators

Globally, one fourth of carnivorous plants are threatened An international research team including botanist Andreas Fleischmann from SNSB-BSM has evaluated the Red List threat categories for all 860 known species…

The smallest particle sensor in the world

Styrian technological innovation – made in Graz TU Graz, ams and Silicon Austria Labs has developed a compact and energy-efficient sensor for mobile devices, which informs users in real time…

Nanostructures with a unique property

Nanoscale vortices known as skyrmions can be created in many magnetic materials. For the first time, researchers at PSI have managed to create and identify antiferromagnetic skyrmions with a unique…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.